Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 9
Submit an article Journal homepage
36
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Simultaneous regression of Philadelphia chromosome and multiple nonrecurrent clonal chromosomal abnormalities with imatinib mesylate in a patient autografted 22 years before for chronic myelogenous leukemia

J. Van Den Akker Department of Cytogenetics, Hopital Saint-Antoine, Assistance Publique Hopitaux de Paris APHP and Université Pierre et Marie Curie (Paris 6), Paris, France
,
P. Coppo Department of Hematology and Cell Therapy, Hopital Saint-Antoine, Assistance Publique Hopitaux de Paris APHP and Université Pierre et Marie Curie (Paris 6), Paris, France
,
M. F. Portnoï Department of Cytogenetics, Hopital Saint-Antoine, Assistance Publique Hopitaux de Paris APHP and Université Pierre et Marie Curie (Paris 6), Paris, France
,
V. Barbu Department of Biochemistry, Hopital Saint-Antoine, Assistance Publique Hopitaux de Paris APHP and Université Pierre et Marie Curie (Paris 6), Paris, France
,
D. Bories Department of Hematology and Molecular Biology, Hopital Henri Mondor, Assistance Publique Hopitaux de Paris APHP and Université Paris XII, Paris, France
&
N. C. Gorin Department of Hematology and Cell Therapy, Hopital Saint-Antoine, Assistance Publique Hopitaux de Paris APHP and Université Pierre et Marie Curie (Paris 6), Paris, FranceCorrespondence[email protected]
Pages 1858-1865 | Received 20 May 2007, Accepted 19 Jun 2007, Published online: 01 Jul 2009

References

  • Melo J V, Deininger M W. Biology of chronic myelogenous leukemia—signaling pathways of initiation and transformation. Hematol Oncol Clin North Am 2004; 18: 545–568, vii – viii
  • Udomsakdi C, Eaves C J, Lansdorp P M, Eaves A C. Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia. Blood 1992; 80: 2522–2530
  • Udomsakdi C, Eaves C J, Swolin B, Reid D S, Barnett M J, Eaves A C. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level. Proc Natl Acad Sci USA 1992; 89: 6192–6196
  • Calabretta B, Perrotti D. The biology of CML blast crisis. Blood 2004; 103: 4010–4022
  • Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 2005; 5: 172–183
  • Druker B J, Talpaz M, Resta D J, Peng B, Buchdunger E, Ford J M, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031–1037
  • Kantarjian H, Talpaz M, O'Brien S, Giles F, Faderl S, Verstovsek S, et al. Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia—comparison with historic experience. Cancer 2005; 103: 2099–2108
  • Deininger M, Buchdunger E, Druker B J. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 2005; 105: 2640–2653
  • O'Brien S G, Guilhot F, Larson R A, Gathmann I, Baccarani M, Cervantes F, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003; 348: 994–1004
  • Nicolini F E, Corm S, Le Q H, Sorel N, Hayette S, Bories D, et al. Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(varphi)-LMC GROUP). Leukemia 2006; 20: 1061–1066
  • Douay L, Mary J Y, Giarratana M C, Najman A, Gorin N C. Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557). Exp Hematol 1989; 17: 429–432
  • van den Akker J, Gorin N C, Laporte J P, Douay L, Lopez M, Taillemite J L, et al. Chromosome abnormalities after autologous bone marrow transplantation with marrow treated by cyclophosphamide derivatives. Lancet 1985; 1: 1211–1212
  • Shah N K, Wagner J, Santos G, Griffin C A. Karyotype at relapse following allogeneic bone marrow transplantation for chronic myelogenous leukemia. Cancer Genet Cytogenet 1992; 61: 183–192
  • Bilhou-Nabera C, Bernard B, Marit G, Viard F, Gharbi M J, Wen Z, et al. Serial cytogenetic studies in allografted patients with chronic myeloid leukemia. Bone Marrow Transplant 1992; 9: 263–268
  • Offit K, Burns J P, Cuningham I, Jhanwar S C, Black P, Kernam N A, et al. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation. Blood 1990; 75: 1346–1355
  • Yoshihara T, Hibi S, Yamane Y, Morimoto A, Hashida T, Iwami H, et al. Numerous nonclonal chromosomal aberrations arising in residual recipient hematopoietic cells following allogeneic bone marrow transplantation. Bone Marrow Transplant 2005; 35: 587–589
  • Baker M C, Lawler S D, Harris H, Barrett A, Powles R L. Radiation damage in patients treated by total-body irradiation, bone marrow grafting, and cyclosporin. Radiat Res 1986; 105: 413–424
  • Perot C, van den Akker J, Laporte J P, Douay L, Lopez M, Stachowiak J, et al. Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide. Leukemia 1993; 7: 509–515
  • Heinze B, Arnold R, Rutzen-Loesevitz L, Fliedner T M. The role of stable chromosome aberrations as biological indicators of radiation effect: studies in patients after total body irradiation and bone marrow transplantation. Stem Cells 1995; 13(Suppl 1)191–198
  • Kebriaei P, Winter J N, Laport G G, Le Beau M M, Dewald G, Larson R A. Multiple unrelated clonal abnormalities in host bone marrow cells after allogeneic stem cell transplantation. Leuk Res 2004; 28: 537–540
  • Wang X, Ahmed I, Ericson S, Wenger S. Multiple chromosome abnormalities following bone marrow transplant for chronic myelogenous leukemia. J Assoc Genet Technol 2004; 30: 7–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.